Jushi Holdings (JUSHF) Net Cash Flow (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Net Cash Flow came in at $15.7 million in Q1 2026, up 139.34% year-on-year from $6.5 million in Q1 2025, and up 3325.6% on a QoQ basis from $457000.0 in Q4 2025.
Jushi Holdings (JUSHF) Net Cash Flow (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Net Cash Flow data on file, last reported at $15.7 million in Q1 2026.
- On a quarterly basis, Net Cash Flow rose 139.34% year-over-year to $15.7 million in Q1 2026; TTM through Mar 2026 was $14.4 million, a 637.32% increase from a year earlier, with the FY2025 full-year figure at $5.3 million, up 152.92% from the prior year.
- Net Cash Flow for Q1 2026 stood at $15.7 million, up from $457000.0 in the prior quarter.
- Over the last five years, Net Cash Flow for JUSHF reached as high as $15.7 million in Q1 2026 and fell as low as -$32.2 million in Q2 2022.
- Historically, Net Cash Flow has averaged -$3.1 million across 5 years, with a median of -$1.5 million in 2024.
- Across the five-year window, Net Cash Flow sank 662.02% in 2024 and jumped 982.73% in 2025, its largest moves.
- Year by year, Net Cash Flow stood at -$5.1 million in 2022, then soared by 116.55% to $836000.0 in 2023, then plunged by 284.81% to -$1.5 million in 2024, then jumped by 129.58% to $457000.0 in 2025, then surged by 3325.6% to $15.7 million in 2026.
- Per Business Quant data, the three most recent Net Cash Flow figures were $15.7 million in Q1 2026, $457000.0 in Q4 2025, and $928000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 15.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.66 Mn |
| Mar 31, 2026 | 15.66 Mn |
| Dec 31, 2025 | 457,000.00 |
| Dec 31, 2025 | 457,000.00 |
| Sep 30, 2025 | 928,000.00 |
| Sep 30, 2025 | 928,000.00 |
| Jun 30, 2025 | -2.66 Mn |
| Jun 30, 2025 | -2.66 Mn |
| Mar 31, 2025 | 6.54 Mn |
| Mar 31, 2025 | 6.54 Mn |
| Dec 31, 2024 | -1.55 Mn |
| Dec 31, 2024 | -1.55 Mn |
| Sep 30, 2024 | -12.14 Mn |
| Sep 30, 2024 | -12.14 Mn |
| Jun 30, 2024 | 4.47 Mn |
| Jun 30, 2024 | 4.47 Mn |
| Mar 31, 2024 | -741,000.00 |
| Mar 31, 2024 | -741,000.00 |
| Dec 31, 2023 | 836,000.00 |
| Dec 31, 2023 | 836,000.00 |